DB
BIIB icon

Danske Bank’s Biogen BIIB Stock Holding History

Danske Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
66,365
+18,948
+40% +$3.62M 0.03% 385
2026
Q1 		$8.69M Sell
47,417
-998
-2% -$184K 0.02% 458
2025
Q4 		$8.52M Buy
48,415
+3,705
+8% +$605K 0.02% 470
2025
Q3 		$6.26M Sell
44,710
-10,686
-19% -$1.44M 0.02% 507
2025
Q2 		$6.96M Sell
55,396
-8,532
-13% -$1.06M 0.02% 485
2025
Q1 		$8.75M Sell
63,928
-15,870
-20% -$2.27M 0.03% 432
2024
Q4 		$12.2M Buy
79,798
+14,114
+21% +$2.38M 0.04% 378
2024
Q3 		$12.7M Buy
65,684
+253
+0.4% +$52.9K 0.04% 341
2024
Q2 		$15.2M Sell
65,431
-18,423
-22% -$4M 0.06% 287
2024
Q1 		$18.1M Buy
+83,854
New +$19.6M 0.06% 295

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Danske Bank's BIIB Position: Q2 2026 in Review

Danske Bank increased its Biogen (BIIB) stake by 40% in Q2 2026, buying an estimated $3.62M and bringing the position to 66,365 shares worth $14.3M. The position accounts for 0.03% of the portfolio, ranked #385.

Danske Bank first reported a position in BIIB in Q1 2024 and has held it in 10 quarters since. The position peaked at $18.1M in Q1 2024. 917 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Danske Bank held 66,365 shares of Biogen worth $14.3M as of Q2 2026.
  • Danske Bank bought 18,948 Biogen shares in Q2 2026, an estimated $3.62M.
  • Biogen made up 0.03% of Danske Bank's portfolio in Q2 2026, its #385 holding.
  • Danske Bank first reported a position in Biogen in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Biogen position peaked at $18.1M in Q1 2024.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.